Trial Details
COMPLETEDBasic Information
| Clinical ID | c1435 |
|---|---|
| Identifier | NCT00449722 |
| Trial Title | OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: mesalazine |
Participant Information
| Sponsor | Dr. Falk Pharma GmbH |
|---|---|
| City | Cologne |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-07-05 |
|---|---|
| Primary Completion Date | - |
| Completion Date | 2025-06-06 |